Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Closes
- May 7, 2029 (in 922 days)
Similar opportunities open now
- Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Jan 2029
- Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Jan 2028Up to $8M
- GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)Same funderOpenNational Institutes of HealthCloses Oct 30, 2026Up to $1.3M
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Mar 2029Up to $250K
Classification and identifiers
- Solicitation number
- PAR-27-111
- Assistance listing (CFDA)
- 93.865
Amount
Amount not listed here. Check the official program.
Who can apply
Public colleges and universities can apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
About this opportunity
The purpose of this notice of funding opportunity (NOFO) is to provide investigators with a mechanism to request services from the state-of-the-art Biological Testing Facility that would advance their contraceptive development or reproductive health programs. This NOFO aims to position innovative and validated methods for future regulatory submission and/or clinical development. Applicants do not need to have current NIH funding to apply, but priority may be given to programs receiving NIH support at the time of application submission.